Balanced news tone
News Sentiment
EW sentiment intelligence
Edwards Lifesciences Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-2.3% over one week, +8.3% over four weeks, trend active, and near fair-value range.
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
EW - Edwards Lifesciences Corp Volatility & Greeks
This article provides a detailed financial overview of Edwards Lifesciences Corp (EW), including its stock performance, market capitalization, income, sales, and various financial ratios. It also presents insider ownership and institutional ownership data, along with volatility m
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 05 Jul 2026 22:08
- Source
- Finviz
How New Valve Trial Data and Index Reclassification Will Impact Edwards Lifesciences (EW) Investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 08:39
- Source
- simplywall.st
If You Invested $1,000 in Edwards Lifesciences Corp (EW)
This article analyzes the historical performance of investing $1,000 in Edwards Lifesciences Corp (EW) over various periods, showing returns ranging from +23.1% in one year to +184.2% over ten years. It also provides a detailed overview of Edwards Lifesciences, a medical technolo
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 08:37
- Source
- Stock Titan
Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Edwards Lifesciences (EW) Stock Weighs DCF Fair Value Against High P/E Multiple
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- simplywall.st
Edwards brings fresh valve data to New York, with TAVR study update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Stock Titan
Why is Edwards Lifesciences stock climbing today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Investing.com
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Edwards Lifesciences Stock (US28176E1082): Valuation metrics under the microscope
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Ad-hoc-news.de
Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Market source
Edwards Lifesciences stock (US28176E1082): NYSE-listed medtech share edges lower as investors digest
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Ad-hoc-news.de
Is Edwards Lifesciences (EW) Fairly Priced After Recent Share Price Strength?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Market source
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 May 2026 07:00
- Source
- Market source
Edwards Lifesciences stock (US28176E1082): heart-valve specialist in focus after latest earnings upd
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 May 2026 07:00
- Source
- Ad-hoc-news.de
Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- StockStory
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 May 2026 07:00
- Source
- Market source
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Market source
US FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jan 2026 08:00
- Source
- Reuters
Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jan 2026 08:00
- Source
- simplywall.st
EW|Edwards Lifesciences Corp|Price:90.110|Chg%:-1.680
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Nov 2025 08:00
- Source
- TradingKey